Cette thèse vise à développer de nouvelles méthodes efficaces pour incorporer des isotopes de l’hydrogène dans les molécules organiques complexes, après une introduction portant sur les applications et la synthèse des molécules marquées par le deutérium et tritium. Les méthodes permettant le marquage, par échange isotopique direct, d’hétérocycles azotés par des isotopes de l’hydrogène restent perfectibles, voire inexistantes dans certains cas, malgré la récurrence de ce type de sous-structures dans les molécules d’intérêt pharmacologique. Pour cette raison, la majeure partie de ce travail a consisté au développement de nouvelles méthodes d’incorporation d’atomes de deutérium et de tritium sur des hétérocycles azotés catalysées par des nanoparticules métalliques. Dans un premier chapitre, la mise au point, le champ d’application d’une méthode de marquage mettant en jeu l’utilisation de nanocatalyseurs de ruthénium seront discutés. Dans ce cadre, des calculs théoriques ont permis de rationaliser les regiosélectivités obtenues expérimentalement et d’identifier notamment des intermédiaires clefs inédits. D’un point de vue applicatif, cette méthode a permis de synthétiser des étalons internes deutérés pour la quantification LC-MS mais aussi des molécules complexes tritiées ayant des activités spécifiques élevées en une étape de synthèse. Dans un autre chapitre, la synthèse et la réactivité de nouveaux nanocatalyseurs de nickel permettant de réaliser des échanges isotopiques sélectifs seront discutés. / This PhD thesis deals with the development of new efficient methods for the incorporation of hydrogen isotopes into organic molecules, which represents a serious issue especially for drug discovery and drug development processes. After giving an introduction about hydrogen isotopes and their applications in organic molecules, the course will proceed to an overview of different chemical transformations for establishing deuterium or tritium labels on molecular frameworks. The possibilities to label N-heterocycles by hydrogen isotopes through hydrogen isotope exchange (HIE) are still very restricted and even impossible for some representatives despite the strong recurrence of these substructures in numerous biologically active molecules. For this reason, the emphasis of the practical part will lie on the development of new methods for the incorporation of deuterium and tritium on N-heterocycles through metal nanoparticle catalysis. In the first chapter, HIE through ruthenium nanocatalysts will be optimized and the application range will be demonstrated. In this context, DFT-based calculations allowed to explain experimental regioselectivities and to identify new keyintermediates. In terms of application, it was shown that the ruthenium-catalyzed method is useful for the synthesis of deuterium labelled internal standards for LC-MS quantifications and for the tritiation of complex molecules displaying satisfying specific activities. In the next chapter, the synthesis of new nickel nanoparticles and their potential to catalyze selective HIE on N-heterocyclic derivatives will be discussed.

L’hypoxie est connue pour être responsable d’une propagation tumorale accrue. En conséquence, les tumeurs hypoxiques nécessitent un diagnostic rapide et précis. L’accès à toutes les localisations tumorales par l’imagerie nucléaire est devenu un intérêt majeur pour l’orientation thérapeutique. Dans la première partie de ce manuscrit, un nouveau traceur de l’hypoxie tumorale marqué au technétium 99m a été développé avec succès. De nouveaux traceurs organosilylés marqués au fluor 18 ont également été étudiés. Un second travail a porté sur le développement d’une nouvelle stratégie de fluoration nucléophile pour la préparation de traceurs TEP. Des essais synthèse du Fluorodésoxyglucose ont été réalisés. L’élaboration de cette stratégie a également conduit au développement d’une nouvelle méthodologie de synthèse de dérivés d’acides sulfoniques par déprotection de thiols au moyen d’hypochlorite de tert-butyle. / It has been recognized that hypoxia plays a major negative role in overall tumor progression. The identification and quantitative estimation of tumor hypoxia by means of nuclear imaging is an important factor in planning the therapeutic strategy for a better clinical outcome. In the present work, a new 99mTc tracer for imaging tumor hypoxia has been successfully developed. New organosilicon fluorinated derivatives were also studied. Every synthesized compounds incorporated a nitroimidazole moiety, which is selectively trapped in hypoxic cells. The second part of this work, led to the development of a new nucleophilic fluorination strategy for the preparation of PET tracers. The new strategy was attempted for the preparation of Fluorodeoxyglucose. In the course of this study, a novel oxidative deprotection method of thiols was developed. Herein was described, the synthesis of sulfonic acid derivatives by oxidative deprotection of thiols using tert-butyl hypochlorite.

No description available.

Bi-annual report on the activities at the ROssendorf BeamLine (ROBL) at the ESRF in Grenoble. The report contains selected contributions on actual research topics, a list of all scheduled experiments, and short experimental reports.

The paper describes the Rossendorf Beamline (ROBL) built by the Forschungszentrum Rossendorf at the ESRF. ROBL comprises two different and independently operating experimental stations: a radiochemistry laboratory for X-ray absorption spectroscopy of non-sealed radioactive samples and a general purpose materials research station for X-ray diffraction and reflectometry mainly of thin films and interfaces modified by ion beam techniques. The radiochemistry set-up is worldwide an unique installation at a modern synchrotron radiation source.

At the beginning of 2011, the former Forschungszentrum Dresden-Rossendorf (FZD) was fully integrated into the Helmholtz Association, as Helmholtz-Zentrum Dresden-Rossendorf (HZDR). Therefore, the present Annual Report 2010 of the Institute of Radiochemistry (IRC) is published as the first HZDR-Report. The Institute of Radiochemistry is one of the six Research Institutes of this centre. IRC contributes to the research program “Nuclear Safety Research” in the “Research Field of Energy” and performs basic and applied research in radiochemistry and radioecology. Motivation and background of our research are environmental processes relevant for the installation of nuclear waste repositories, for remediation of uranium mining and milling sites, and for radioactive contaminations caused by nuclear accidents and fallout. Because of their high radiotoxicity and long half-life the actinides are of special interest.

Le marquage radioisotopique est un domaine d’intérêt d’un point de vue de la recherche fondamentale en santé et, de par ses nombreuses applications, aussi bien en industrie pharmaceutique et agrochimique que dans le milieu académique. Dans ce contexte, le carbone-14 joue un rôle primordial dans le développement de nouvelles drogues et dans les études ADME et toxicologiques. Les voies de synthèse traditionnelles impliquant le ¹⁴C sont longues et multi-étapes ce qui entrave la viabilité de cette stratégie. L’objectif de cette thèse est de développer de nouvelles techniques de radiomarquage par échange isotopique. Dans un premier temps, nos efforts se sont portés sur le développement d’un échange d’isotopes du carbone (EIC) dynamique entre le ¹³CO₂ ou le ¹⁴CO₂, une source fondamentale et facile d’accès de carbone radioactifs et des acides carboxyliques (hétéro)aromatiques par le biais d’une catalyse au cuivre. Le concept de EIC a ensuite été appliqué à d’autres fonctions, présentes dans de nombreux agents pharmaceutiques, les acides phénylacétiques. Une nouvelle approche, sans métaux de transition, a pu être décrite, permettant d’effectuer le marquage avec le ¹³CO₂, le ¹⁴CO₂ et le ¹¹CO₂. Enfin, un autre EIC faisant intervenir le cyanure comme source primaire de carbone radioactif a été conçu. Le développement de l’EIC a permis d’étendre le concept de marquage en dernière étape de synthèse à des substrats contenant une fonction nitrile ou acide carboxylique, en réduisant les coûts et en limitant la génération de déchets radioactifs. Ce concept, encore en voie de développement, offre des alternatives aux méthodes existantes. / Radioisotope labeling is a relevant topic both from a fundament research perspective and for health applications in academy and pharmaceutical and agrochemical industries. In this context, carbon-14 plays a basic role in drug development and ADME and toxicological studies. Traditional synthesis with radiocarbon (¹⁴C), based on lengthy and multistep approaches, have hampered the sustainable of the strategy. The aim of this thesis is to develop novel labeling techniques by isotope exchange. At first, our efforts were focused on the developement of a copper catalyzed dynamic carbon isotope exchange (CIE) using ¹³CO₂ and ¹⁴CO₂, a fundamental and readily available source of radiocarbon on (hetero)aromatic carboxylic acids. The concept of CIE was further extent to another relevant drug scaffolds such as phenyl acetic acids. Hence, it was described a transition metal-free approach able to exchange ¹³CO₂, le ¹⁴CO₂ and ¹¹CO₂, to the best of our knowledge this would be the first example. At last, another CIE with a different primary radiocarbon source such as cyanyde was envisioned. CIE technology expands the concept of late-stage carbon radiolabeling, with substrates bearing carboxylic acid and nitrile moieties, reducing the synthetic costs and limiting the generation of radioactive waste. This new process is still at its infancy and more work need to be done.

Les composés marqués aux isotopes de l’hydrogène possèdent des nombreuses applications lors des phases précliniques de développement des médicaments. Par exemple, les composés deutérés sont utilisés comme étalons internes dans la quantification par LC-MS de métabolites alors que les molécules tritiées sont souvent des radiotraceurs de choix dans les études d’absorption, distribution, métabolisme et excrétion (ADME) moléculaire des candidats médicaments. Après une brève introduction, un premier chapitre discutera du développement d’une méthode douce et sélective, catalysée par des nanoparticules de ruthénium, qui permet d’effectuer le marquage en une étape de bases azotées et de médicaments dérivés. En changeant le ligand qui stabilise le nanocatalyseur, on a réalisé des échanges isotopiques compliqués tels que des tritiations en utilisant une pression sous-atmosphérique de tritium gaz et des deutérations d’oligonucleotides sensibles. Le chapitre suivant décrira la modification des catalyseurs commerciaux à base de ruthénium grâce à la coordination de carbènes N-hétérocycliques (NHCs). La modification assure une régio- et une chimiosélectivité améliorées lors de la deutération d’alcools aliphatiques. Certains des catalyseurs modifiés ont permis l’échange hydrogène/deutérium sur des molécules, particulièrement sensibles à la réduction, qui n’ont pas pu être isolées en utilisant le catalyseur commercial. Dans le dernier chapitre, la synthèse et l’évaluation de l’activité catalytique des nanoparticules à base d’iridium seront discutées. Ces nanocatalyseurs ont démontré une réactivité intéressante dans le marquage des composés complexes. Dans certains cas, les nanoparticules d’iridium ont permis l’incorporation de deutérium sur des positions inhabituelles en comparaison avec d’autres réactions d’échange isotopique déjà décrites. / Hydrogen isotopes labelled compounds possess a broad range of application in the early pre-clinical phases of drug development process. For instance, deuterated compounds are applied as internal standard in quantitative LC-MS techniques while tritiated molecules are often the preferred radioactive tracers for the study of molecular absorption, distribution, metabolism and excretion (ADME). After a brief introduction, a first chapter will discuss the development of a mild and selective method to perform late stage labelling of variously functionalized nucleobases and drug analogues catalyzed by ruthenium nanoparticles. By changing the ligand which stabilizes the nanocatalyst, we achieved challenging isotopic exchanges such as tritiations of pharmaceuticals using subatmospheric pressure of tritium gas and deuteration of sensible oligonucleotides. The next chapter will describe the modification of commercially available ruthenium nanocatalysts via the coordination of N-Heterocyclic carbenes (NHCs). The modification granted enhanced regio and chemoselectivity for the deuteration of aliphatic alcohols. Some of the modified ruthenium catalysts allowed the hydrogen/deuterium exchange on easily reducible compounds which were not obtainable using the unmodified commercial catalyst. The final chapter will discuss the synthesis and the evaluation of the catalytic activity of iridium nanoparticles. The latter, showed an interesting reactivity for the labelling of challenging substrates. In some of the investigated compounds, IrNps were able to introduce deuterium with unusual regioselectivities compared to already described hydrogen isotope exchange reactions.

<p>A series of new methodologies to link a neurotransmitter receptor targeting vector (WAY) to carboranes and the preparation of the corresponding metallocarboranes (M = Re, ^99mTc) as a new class of organometallic CNS imaging probes is described. WAY-carboranes (<strong>5</strong>, <strong>6</strong>, <strong>16</strong>) and the corresponding metallocarboranes (M = Re (<strong>12</strong>, <strong>13</strong>, <strong>22a</strong>, <strong>22b</strong>), ^99mTc (<strong>14a</strong>, <strong>15</strong>, <strong>23</strong>)) were synthesized in yields ranging from 10-95%. The first observed 3,1,2 versus 2,1,8 rhenacarborane isomerization process was discovered for <strong>12</strong> where isomerization and complexation occurred simultaneously. Re-carboranes <strong>22a</strong> and <strong>22b</strong> had similar carbon-carbon cage configuration where electronic effects was the driving force behind isomerization.</p> <p>The lipophilicities of ^99mTc-carboranes (<strong>14a</strong>, <strong>15</strong>, <strong>23)</strong> were within the ideal range to cross the BBB (log P = 2.4-2.6). <em>In vitro</em> binding data showed that <strong>22b</strong> has high affinity for alpha-adrenergic receptors (K_i = 17-39 nM) resulting in the first organometallic complex to effectively bind to this class of receptors. SPECT images of <strong>14a</strong> in rats showed no brain uptake, while quantitative biodistribution studies indicated modest, non-negligible brain uptake in the hypothalamus region.</p> <p>The neutral [M(CO)₂(NO)(C₂B₉H₁₀R)] analogues (<strong>30</strong>, <strong>34</strong>, <strong>37</strong>) were prepared to address the limited brain uptake of the [M(CO)₃(C₂B₉H₁₀R)]^- complexes. Reactivity differences between Re and ^99mTc were noted during nitrosation conditions where the initial products from the reaction led to nitration of the phenyl group in addition to nitrosation of the metal core. The fluorescence properties of <strong>29</strong> were measured.</p> <p>Low yields and multistep syntheses associated with the preparation of substituted carborane led to the development of a carborane-alkyne platform. Alkyne-carboranes (<strong>53</strong>-<strong>55</strong>) were developed and conjugated to WAY-azide (<strong>46</strong>) using “click” chemistry. The metallocarboranes (M = Re (<strong>69</strong>-<strong>71</strong>), ^99mTc (<strong>72</strong>-<strong>74</strong>)) were generated in yields ranging from 45-71%.</p> / Doctor of Philosophy (PhD)

<p>The synthesis of new macromolecular diagnostic imaging agents has been a growing field in polymeric chemistry research. Dendrimers provide a viable scaffold for such applications due to their unique, defined macromolecular architecture. The precise structural control afforded via the step-wise synthesis of dendrimers yields exceptional and precise macromolecules that can be functionalized to include necessary imaging moieties with the same degree of precision.</p> <p>We have herein contributed to this growing field by attempting the synthesis of a series of PEGylated poly(2,2-bis[hydroxymethyl]propanoic acid) PMPA dendrons using thiol-ene "click" chemistry. The series consisted of three dendritic architectures peripherally functionalized with poly(ethylene glycol) (PEG) chains of varying length (n= 3, 8, 16), with the goal of determining the effect of PEG chain length on blood circulation times. Synthesis of these conjugates began first with functionalization of the dendron periphery to incorporate alkene functionalities using anhydride-mediated esterification chemistry.</p> <p>The core of the alkene PMPA dendrons was then modified to introduce a metal chelating bis-pyridyl functionality, which has been observed to chelate the radionuclide technetium-99m (^99mTc) with high binding affinity. ^99mTc is the most widely used diagnostic radioisotope in diagnostic medicine due to its ideal isotopic properties, widespread availability, low cost, and its ability to be traced, in real time, <em>in vivo</em> using Single Photon Emission Computed Tomography (SPECT).</p> <p>PEGylation at the periphery was performed by thiol-ene “click” chemistry using thiol-terminated PEG chains. Metallation of the core of each PEGylated dendron was then attempted according to literature procedures for ^99mTc radiolabeling with the bis-pyridyl chelate.</p> / Master of Science (MSc)